CCR5 mAb

Related by string. * : CCR5 tropic HIV . CCR5 doorway . CCR5 receptor antagonists . CCR5 antagonists . CCR5 antagonist . CCR5 receptor antagonist . CCR5 CXCR4 . CCR5 receptor / mAbs . MABS . MAB . MAbs . Med AB . MAb . Mab . Mabs : monoclonal antibodies MAbs . WAM MAB . monoclonal antibodies mAbs . Butlers Plc MAB LN . Biosphere MAB . monoclonal antibody IgG1 Mab . monoclonal antibody mAb * *

Related by context. Frequent words. (Click for all words.) 72 forodesine 71 INCB# [001] 70 AEG# 70 Initiate Phase 68 GRNVAC1 67 Panzem R 67 Cethromycin 67 Factor VIIa 67 CCX# 67 Presents Positive 67 refractory chronic lymphocytic 67 PEG SN# 66 Aurexis 66 MEK inhibitor 66 Protexia R 66 KNS # 66 Pivotal Phase III 66 DDP# 66 phase Ib 66 KRN# 66 Daclizumab 66 Belimumab 66 PEG Interferon lambda 65 HGS ETR1 65 CR# vcMMAE 65 MKC# 65 Metastatic Melanoma 65 Pivotal Phase 65 R sorafenib tablets 65 therapeutic monoclonal antibodies 65 Completes Enrollment 65 AMD# [002] 65 thymalfasin 65 VGV 1 65 ALN VSP 65 ganetespib 64 eniluracil 64 polymerase inhibitor 64 Entereg R 64 Shigamabs ® 64 Golimumab 64 OncoVEX GM CSF 64 MNTX 64 phase IIb clinical 64 ZALBIN 64 Phase Ib II 64 targeting CD# 64 Hepatitis C Virus HCV 64 liposomal formulation 64 elotuzumab 64 LymphoStat B 64 daptomycin 64 Traficet EN 64 MVA BN R 64 ApoB SNALP 64 IMC #B 64 PSN# [002] 64 diabetic neuropathic pain 63 NEUMUNE 63 ongoing Phase 1b 63 tezampanel 63 antisense drug 63 Azedra 63 Allovectin 7 R 63 Initiates Phase 63 Phase III Clinical Trial 63 Aliskiren 63 Phenoptin 63 TOLAMBA 63 CORT # 63 Sym# 63 metreleptin 63 Inc. Nasdaq IMGN 63 Kuvan R 63 orally bioavailable 63 INT# [002] 63 ZFP Therapeutic 63 APTIVUS 63 OXi# 63 Ramoplanin 63 HCV protease inhibitor 63 nucleoside reverse transcriptase inhibitor 63 methylnaltrexone 63 tanespimycin 63 Zadaxin 63 drug conjugate 63 Dapagliflozin 63 Bicifadine 63 siRNA therapeutics 63 Clinical Trial Results 63 Mipomersen 63 registrational trial 63 Shigamabs R 62 Phase 2a trial 62 Epratuzumab 62 faropenem 62 pradefovir 62 SAR# [004] 62 Phase 1b trial 62 Phase Ib clinical 62 nicotinic alpha 7

Back to home page